This manuscript details a novel therapeutic strategy for cancer treatment based on the mitochondrial-stem cell connection (MSCC) theory, which posits that cancer arises from impaired mitochondrial function in stem cells. The manuscript proposes a hybrid orthomolecular protocol that combines orthomolecules, drugs, and additional therapies targeting the MSCC. The protocol aims to enhance oxidative phosphorylation, inhibit cancer cell fuels, target cancer stem cells and metastases, and promote overall cellular health. The authors provide evidence from various studies and case reports supporting the efficacy of the proposed protocol and its potential benefits over conventional cancer therapies.

https://isom.ca/article/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment-a-hybrid-orthomolecular-protocol/